Verition Fund Management’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,000
Closed -$20K 2958
2022
Q3
$20K Buy
+25,000
New +$21.5K ﹤0.01% 2791
2022
Q2
Sell
-25,000
Closed -$48K 3220
2022
Q1
$48K Hold
25,000
﹤0.01% 2494
2021
Q4
$55K Hold
25,000
﹤0.01% 2403
2021
Q3
$93K Hold
25,000
﹤0.01% 1717
2021
Q2
$150K Sell
25,000
-15,000
-38% -$79.3K ﹤0.01% 1645
2021
Q1
$264K Buy
+40,000
New +$263K ﹤0.01% 1183

Other funds holding ARAV

Verition Fund Management's ARAV Position: Q4 2022 in Review

Verition Fund Management sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2022, closing a stake of 25,000 shares — an estimated $20K sold.

Verition Fund Management first reported a position in ARAV in Q1 2021 and held it in 6 quarters. The position peaked at $264K in Q1 2021. 32 funds tracked by Wall St. Rank hold ARAV as of Q4 2022.

  • Verition Fund Management reported no remaining Aravive, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 25,000 Aravive, Inc. Common Stock shares in Q4 2022, an estimated $20K.
  • Verition Fund Management first reported a position in Aravive, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Verition Fund Management's Aravive, Inc. Common Stock position peaked at $264K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.